Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07404826

PEP Buddy in Pulmonary Rehabilitation

A Randomized, Sham Controlled Clinical Trial to Assess the Effectiveness of a Positive End Expiratory Device for Accelerating and Maintaining Pulmonary Rehabilitation Gains

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
VA Office of Research and Development · Federal
Sex
All
Age
40 Years – 89 Years
Healthy volunteers
Not accepted

Summary

In this study, the investigators will test Veterans with COPD in Pulmonary Rehabilitation. Between two groups, the investigators will give one group a device that assists with breathing and symptoms and the other receives a 'sham' device which does not provide these benefits. The investigators will test to see if the symptoms and exercise capacity of the group who receives this device improves faster in Pulmonary Rehabilitation and has longer lasting benefits after the end of Pulmonary Rehabilitation.

Detailed description

In this randomized, double-blinded, sham-controlled clinical trial, the investigators will test the effectiveness of the use of a positive expiratory device (PEP Buddy) vs. sham in participants with COPD in Pulmonary Rehabilitation and after discharge from Pulmonary Rehabilitation for up to one year. The investigators will compare changes in quality of life metrics and measurements of functional capacity between the intervention and sham groups over the course of the study.

Conditions

Interventions

TypeNameDescription
DEVICEPEP BuddyThis is a small, portable device worn about the neck with a lanyard, that can be used to control symptoms of breathlessness associated with chronic lung disease.
DEVICEPEP Buddy ShamA Device that appears the same as PEP Buddy but only provides the expiratory pressure of the standard-of-care pursed lip breathing

Timeline

Start date
2026-04-01
Primary completion
2030-03-29
Completion
2030-03-29
First posted
2026-02-12
Last updated
2026-02-17

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07404826. Inclusion in this directory is not an endorsement.